Sunday, November 3, 2024
HomeTagsOrphan Medicinal Product

Orphan Medicinal Product

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, announced that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics